A. Kaneko

Characterization of Two Novel Retinoic Acid‐resistant Cell Lines Derived from HL‐60 Cells Following Long‐term Culture with all‐trans‐Retinoic Acid

K. Ichikawa, T. Kakizawa, K. Hashizume, 1999, Japanese journal of cancer research : Gann.

1,25-Dihydroxyvitamin D3 suppresses the expression of the VCAM-1 receptor, VLA-4 in human leukemic HL-60 cells.

K. Ichikawa, T. Kakizawa, K. Hashizume, 1999, Biochemical and biophysical research communications.

Mechanism of liver-selective thyromimetic activity of SK&F L-94901: evidence for the presence of a cell-type-specific nuclear iodothyronine transport process.

K. Ichikawa, T. Kakizawa, K. Hashizume, 2000, The Journal of endocrinology.

Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves disease. A novel side effect of antithyroid drugs.

K. Ichikawa, K. Hashizume, T. Aizawa, 1997, Archives of internal medicine.

Reversal of Insulin-Requiring Diabetes after the Resection of a Large-Sized, Epinephrine-Dominant Pheochromocytoma, Following 9-Year Treatment of Diabetes without Hypertension

Y. Aoki, A. Kaneko, M. Kumagai, 2021 .

Functional Interaction between Oct-1 and Retinoid X Receptor*

K. Ichikawa, T. Kakizawa, K. Hashizume, 1999, The Journal of Biological Chemistry.

Inhibition of Peroxisome Proliferator Signaling Pathways by Thyroid Hormone Receptor

K. Kamijo, T. Kakizawa, K. Hashizume, 1997, The Journal of Biological Chemistry.

The role of hinge domain in heterodimerization and specific DNA recognition by nuclear receptors

K. Ichikawa, T. Kakizawa, T. Miyamoto, 2001, Molecular and Cellular Endocrinology.

Ligand-dependent Heterodimerization of Thyroid Hormone Receptor and Retinoid X Receptor*

K. Ichikawa, T. Kakizawa, K. Hashizume, 1997, The Journal of Biological Chemistry.